| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.0067 | 1 |